The findings of anti-fibrillarin reactivity in SLE and SjS patients in this cohort as well as the antibody profile suggest a potential overlap syndrome of the patient samples and can also be related to previous findings of anti-fibrillarin antibodies in patients with more severe disease or with lupus [36]. The gene discussed is FBL; the disease is systemic lupus erythematosus.